Topics

Companies Related to "Grants Breakthrough Device Designation KidneyIntelX Enabled Diagnostic Kidney" [Most Relevant Company Matches] RSS

18:06 EDT 15th September 2019 | BioPortfolio

Here are the most relevant search results for "Grants Breakthrough Device Designation KidneyIntelX Enabled Diagnostic Kidney" found in our extensive corporate database of over 50,000 company records.

Showing "Grants Breakthrough Device Designation KidneyIntelX Enabled Diagnostic Kidney" Companies 1–25 of 4,100+

Relevant

A1M Pharma

A1M Pharma develops a diagnostic method and a novel treatment for the damaging effects of pre-eclampsia, a condition that affects around 10 million pregnant women worldwide. This disorder is responsible for 76,000 maternal and 500,000 infant deaths each year. It is also the cause of 15 per cent of all premature births. Currently, there is no predictive diagnostic method or treatment for impairme...


National Kidney Foundation

The National Kidney Foundation, with offices throughout the country, is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing availability of all organs for transplantation. More at www.kidney.org.

Kidney Research UK

Kidney disease is not, as commonly thought, a disease that affects only the elderly - it can happen at any age. Treatment options include a transplant - for which there is a waiting list or a life on dialysis, a life sustaining treatment - but which can severely restrict daily life.Founded in 1961, Kidney Research UK is the leading UK charity funding research that focuses on the prevention, treatm...


The Kidney TRUST

Founded in 2006, the TRUST is a non-profit organization dedicated to reducing the human and economic cost of kidney disease. The TRUST is focused on increasing awareness of chronic kidney disease (CKD) through public education and testing programs so that progression of CKD to kidney failure can be delayed or prevented. The TRUST is also developing innovative solutions to address the critical un...

Thrasos Therapeutics

Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Thrasos’...

Ixion Biotechnology

Dedicated to discovering and developing breakthrough cell-based therapies for metabolic disorders including primary hyperoxaluria, kidney stones, and other oxalate-related conditions, and insulin-dependent diabetes.

Trudeau Institute

The Trudeau Institute is an independent, not-for-profit, biomedical research organization, whose scientific mission is to make breakthrough discoveries leading to improved human health. Trudeau immunologists are committed to making breakthrough research discoveries that will prevent and treat cancer, asthma, allergy, arthritis, colitis, multiple sclerosis,...

The UC Discovery Grant

The Industry-University Cooperative Research Program (IUCRP) awards MICRO Grants and UC Discovery Grants in five fields of science and engineering. UC Discovery Grants form a 3-way partnership between UC, Industry Sponsors, and the State of California. Winter 2002 The Industry-University Cooperative Research Program (IUCRP) reorganizes, creating one administrative base for UC Discovery GrantsFall ...

Arch Grants

Arch Grants creates an entrepreneurial culture and infrastructure to build successful companies in St. Louis. The organization provides $50,000 equity-free grants and pro bono support services to entrepreneurs eager to locate or retain their early-stage businesses in St. Louis. For more information, visit archgrants.org.

National Kidney Foundation Singapore

The World Kidney Fund was established as an international fund by the National Kidney Foundation Singapore to help kidney patients in developing countries who have little or no access to renal healthcare facilities. Through this fund, training programmes are developed to empower non-profit kidney organisations to establish sustainable life-saving kidney healthcare programmes. The World Kidney Fun...

Medstone International Incorporated

Medstone International Inc., a leader in shockwave therapy treatment and the first and only device approved in the U.S. for the dual therapy to treat kidney stones and now even a larger market of gallstones. The Company has been providing solutions for treatment of kidney stones for over 10 years. Medstone, the only US manufacturer of lithotripters, has recently introduced the latest innovation i...

Kibow Biotech Inc

Kibow Biotech Inc. was founded in 1997 by Dr. N. Ranganathan and Dr. Jack Dickstein. Kibow Biotech Inc. started out to fill the void in treatments for patients with chronic kidney disease. Since then Kibow Biotech Inc. has been actively researching on ways and methods to develop a cost-effective non-invasive treatment for kidney disease patients. This has since became our mission statement. The co...

VentriPoint Diagnostics

VentriPoint creates diagnostic tools to monitor patients with heart disease -- the number one cause of death in developed countries. By using images produced from existing medical imaging systems, the VentriPoint Diagnostic System generates accurate heart measurements in a rapid and inexpensive manner not currently available. This breakthrough diagnostic tool is based upon patented technology ...

MindFrame, Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes fo...

Thrasos, Inc.

Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company has advanced two compounds, THR-184 and THR-123, into development for Acute Kidney Injury (AKI) and Chronic Kidney Injury (CKD), respectively, and initiated Phase 1 cli...

Emmaus Life Sciences, Inc.

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sickle cell disease and sickle beta-0 thalassemia was initiated by Dr. Niihara at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The therapy has Orphan D...

Marin General Hospital Corp.

The breast cancer program at Marin General Hospital, which includes Marin Cancer Institute and the Breast Diagnostic Center of Marin, is one of just 11 programs in California that have received accreditation from the American College of Surgeons National Accreditation Program for Breast Centers (NAPBC). The Breast Diagnostic Center of Marin recently...

Jewish Community Foundation

The Foundation’s General Community Grants provide financial support to organizations and programs that strengthen the fabric of society and are not affiliated with Jewish causes. Over the last five years, General Community Grants have contributed nearly $750,000 to almost 60 L.A. based community organizations, ranging from education to social services ...

PercSys

Approximately 1.7 million people in the U.S. experience kidney stones each year. Half of those will have at least one recurrence during their lifetime. One in four will find it necessary to undergo endoscopic lithotripsy (PCNL or ureteroscopic stone treatment). Once primarily a male affliction, kidney stone disease is increasingly affecting women, who now constitute two of every five cases diagn...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc. is a world leader in discovery and development of novel small interfering RNA, or siRNA, therapeutics for unmet medical needs. RNA interference is a biological process in which RNA molecules regulate expression of targeted genes. Quark’s fully integrated drug discovery and development platform spans the process from therape...

ScottCare Cardiovascular Solutions

ScottCare develops, markets and sells cardiac monitoring products and services for cardiology offices, hospitals and independent diagnostic testing facilities to aid in the diagnosis and management of cardiovascular disease. ScottCare is the market leader in cardiopulmonary rehabilitation monitoring solutions and provides the industry's only single platfor...

Ardian

Ardian, Inc., headquartered in Palo Alto, California, is a private medical device company developing a novel catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. These interdependent disease states represent a significant, escalating global health issue. Ardian is the eighth company created...

Oriel Therapeutics Inc.

Oriel Therapeutics is a leading respiratory drug delivery and development company serving the pharmaceutical, biotechnology, and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and COPD.Our roots are steeped in breakthrough aerosolization technology - which enabled the development of i...

STAT-Diagnostica

Founded in 2010 in Barcelona, STAT-Diagnostica is focused on the development of Near Patient Testing solutions where fast and accurate diagnostic results are needed. Its in vitro diagnostic system is a versatile, easy-to-use platform that consolidates molecular and immunoassay techniques in a single device.


More From BioPortfolio on "Grants Breakthrough Device Designation KidneyIntelX Enabled Diagnostic Kidney"

Quick Search

Corporate Database Quicklinks